Indonesian customers inspected the pre-filled filling line of ALWELL in Shanghai, and the order production progress was highly recognized
A delegation of well-known Indonesian pharmaceutical companies visited the Songjiang production base of Shanghai ALWELL Machinery Equipment Co., Ltd. (ALWELL) today, focusing on supervising the production progress of the high-speed prefilled syringe filling machines and supporting production lines they ordered.
Dynamic demonstration of intelligent production line
pre-filled filling line
The customer watched the demonstration of the core filling process in the workshop:
Precision filling system
using metering pump quantitative technology, filling error ≤±1%, equipped with anti-drip device to eliminate liquid medicine waste
Modular design
the production line adapts to various specifications of syringes such as 1mL/2.5mL/5mL through rapid replacement of parts, and the switching time is <30 minutes
Full traceability
the integrated visual inspection system removes defective products in real time, the interception rate of defective products reaches 99%, and the data is uploaded to the platform synchronously.
Confirmation of order pre-filled filling line progress
The production director shows the customer the work order execution board: Current order completion rate: 78% (12% ahead of the original plan)
In-depth technical communication
The engineering team explains three major innovations:
"We upgraded the vacuum laminar flow protection system in this batch of equipment, and the environmental cleanliness of the filling area has been improved. At the same time, 316L stainless steel contact surface materials are used to meet the corrosive requirements of antibody biologics filling."
【Customer Feedback】
BioPharma Purchasing Director said:
"ALWELL's pre-filled filling line control system far exceeded expectations! The real-time updated electronic work order system in the workshop allows us to accurately grasp the status of each component. Its filling accuracy and cross-contamination prevention and control plan fully comply with FDA prefilled needle catheter product specifications, and the second phase expansion plan has been preliminarily discussed.
